Botulinum toxin type A for gummy smile
Journal of Digital Health and Advanced Biomaterials · 24.03.2026 · 1 (1) · 5-13
DOI: 10.67463/2pcxgv61 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Digital Health and Advanced Biomaterials, online erschienen am 24.03.2026. Verfasst von Diego Silva. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
To critically reassess the use of botulinum toxin type A (BoNT/A) for gummy smile, with emphasis on anatomical targeting, protocol variability, and the conditions required for reproducible outcome measurement.Data sources: Literature addressing etiologic phenotyping of gummy smile, elevator-muscle anatomy, BoNT/A formulation and preparation, targeted clinical application, and digital approaches to image-based outcome capture.Eligibility criteria: Studies and technical sources were prioritized when they directly informed five linked domains: phenotype selection, anatomical rationale, product handling, delivery variables, and the reliability of endpoint documentation.Methods of synthesis: Critical narrative review integrating anatomical, clinical, pharmaceutical, and measurement-oriented evidence relevant to the translational interpretation of BoNT/A therapy for gummy smile.Main findings: The literature supports temporary gingival-display reduction in selected muscular cases and offers a credible anatomical rationale for targeting the Yonsei region. However, universality of the point is not supported. Morphometric variation, heterogeneous smile-task architecture, non-equivalent product preparation, and incompletely reported dose-volume-depth relationships remain major interpretive barriers.
Conclusion
BoNT/A remains a defensible minimally invasive option for compatible muscular etiologies, but the field will mature only when anatomical targeting, product handling, dose-volume-depth architecture, smile-task definition, and digitally auditable outcome measurement are integrated within one reproducible protocol.
Zitieren
APA
Silva, D. (2026). Botulinum toxin type A for gummy smile. Journal of Digital Health and Advanced Biomaterials, 1(1), 5-13. https://doi.org/10.67463/2pcxgv61
Vancouver
Silva D. Botulinum toxin type A for gummy smile. Journal of Digital Health and Advanced Biomaterials. 2026;1(1):5-13. doi:10.67463/2pcxgv61
BibTeX
@article{Silva2026,
author = {Silva, Diego},
title = {Botulinum toxin type A for gummy smile},
journal = {Journal of Digital Health and Advanced Biomaterials},
year = {2026},
volume = {1},
number = {1},
pages = {5--13},
doi = {10.67463/2pcxgv61}
}
EUVIMED